GE HealthCare to Report Q1 2026 Earnings

The healthcare division will announce its first quarter financial results on April 29th.

Apr. 6, 2026 at 12:41pm

Got story updates? Submit your updates here. ›

GE HealthCare, the recently spun-off medical technology and healthcare division of General Electric, will report its first quarter 2026 financial results on April 29, 2026. The company was separated from GE's core industrial businesses in 2023 and is now an independent publicly traded entity.

Why it matters

As a newly independent company, GE HealthCare's quarterly earnings will be closely watched by investors to gauge the performance and growth potential of the healthcare technology and services business. The Q1 2026 report will provide the first comprehensive financial snapshot of GE HealthCare since the spin-off.

The details

GE HealthCare was created through the separation of GE's healthcare assets, including its medical imaging, ultrasound, patient monitoring and pharmaceutical diagnostics businesses. The spin-off was completed in early 2023, making GE HealthCare a standalone publicly traded company on the Nasdaq exchange.

  • GE HealthCare was spun off from General Electric in early 2023.
  • GE HealthCare will report its first quarter 2026 financial results on April 29, 2026.

The players

GE HealthCare

A medical technology and healthcare company that was spun off from General Electric in 2023, now operating as an independent publicly traded entity.

General Electric

The industrial conglomerate that previously owned GE HealthCare as part of its diversified business portfolio.

Got photos? Submit your photos here. ›

What’s next

Investors will closely analyze GE HealthCare's Q1 2026 earnings report to assess the company's financial health, growth prospects, and strategic direction as an independent entity.

The takeaway

The reporting of GE HealthCare's first quarterly results as a standalone public company marks a significant milestone in the evolution of the healthcare technology business, providing greater transparency and accountability as it competes in the dynamic medical devices and services market.